Clinical Study

Electrophysiological Studies in Patients with Pulmonary Hypertension: A Retrospective Investigation

Table 4

Hemodynamic parameters.

All patientsPatients with PH group 1 ( )Patients with PH group 2 ( )Patients with PH group 4 ( )

Characteristics
 Age64596762
 Female288113
 CHD10163
Echocardiography
 sPAP (mm Hg)58665268
 LA-diameter (mm)50416041
 LV-diameter (mm)49445345
 LV-EF (reduction)No: 32No: 13No: 7No: 4
Low: 13Low: 1Low: 9Low: 2
Middle: 5Middle: —Middle: 3Middle: 2
High: 4High: —High: 4High: —
 RA-diameter (mm)58615759
 RV-diameter (mm)43463850
 TAPSE (mm)16.5161615
 TEI-Index0.550.60.520.55
 AT (msec)81737973
 LVH ( )171103
Right heart catheterization
 PCWP (mm Hg)1592210
 mPAP (mm Hg)42434142
 PVR (dyn s cm−5)647835515640
 RAP (mm Hg)98119
 CO (L/min)3.93.53.94.1

CHD: coronary heart disease, sPAP: systolic pulmonary arterial pressure, LA/RA=left/right atrium, LV/RV: left/right ventricle, EF: ejection fraction, TAPSE: tricuspid annular plane systolic excursion, AT: acceleration time, LVH: left ventricle hypertrophy, PCWP: pulmonary capillary wedge pressure, mPAP: mean pulmonary arterial pressure, PVR: pulmonary vascular resistance, RAP: right atrial pressure, and CO: cardiac output (litres (L) per minute (min)).